Fully invested in Expertise

Our Team

Launch Therapeutics is backed by leading investors, Carlyle and its life sciences franchise, Abingworth.

Launch Tx was formed in 2022 with the vision of assembling an exceptional team that could redefine late-stage development. The goal? Expediting the pathway for therapies to be approved, and ultimately, delivered to the patients who need them. Meet the team of passionate professionals who are deeply committed to both the science – and the art – of delivering on that promise.

Leadership Team
Board of Directors
Advisory Committee

Former CCO and EVP, PPD
Board Director for Saama, TriNetX

Anshul Thakral

Co-Founder, Launch Therapeutics
Chief Executive Officer

Previously SVP of Development Operations, PPD

Elisha Talley-Roithner

Head of Operations

Previously VP of Clinical Development, BeiGene

Shao Chang, MD, PhD

Chief Medical Officer

Previously Chief of Regulatory Affairs with EQRX

Michael Doherty

Chief Regulatory Officer

Previously CEO, Immune Design

Carlos Paya, MD, PhD

Head of R&D

Previously VP of Development Operations, PPD

Matthew Cramblett

Head of Clinical Operations

Previously Head of Partnership Excellence, PPD

Laura Batchelor

Head of Alliance Management

Previously CBO, Nuvelution

James Cornwall, PhD

Head of Business Development

Previously Global Head of Biostatistics, ICON

Aaron Camp

Head of Biometrics

David Simmons

Chairman of the Board

Kurt von Emster, CFA

Co-Founder, Launch Therapeutics
Managing Partner and Head of Abingworth Life Sciences, Abingworth

Steve Wise

Managing Director & Global Head of Healthcare, Carlyle

Joe Bress

Managing Director, Carlyle

Bali Muralidhar

Managing Partner, Chief Investment Officer & COO, Abingworth

Anshul Thakral

Co-Founder, Launch Therapeutics
Chief Executive Officer

David Simmons

Former Chairman & CEO, PPD

William Sharbaugh

Former President & COO, PPD

Ian Read

Former Chairman & CEO, Pfizer

Laura Hamill

Former EVP, Worldwide Commercial Operations, Gilead

Scott Brun

Former VP,  Scientific Affairs & Head of AbbVie Ventures, AbbVie

Together, We Deliver Excellence

A powerhouse of seasoned industry experts, the Launch Tx leadership team has achieved remarkable milestones and driven groundbreaking studies. Let's break it down by the numbers:


Phase 3 studies


years in drug development
leadership roles


assets brought to market